848 related articles for article (PubMed ID: 27739880)
1. The performance of HPMC matrix tablets using various agglomeration manufacturing processes.
Košir D; Vrečer F
Drug Dev Ind Pharm; 2017 Feb; 43(2):329-337. PubMed ID: 27739880
[TBL] [Abstract][Full Text] [Related]
2. Does the performance of wet granulation and tablet hardness affect the drug dissolution profile of carvedilol in matrix tablets?
Košir D; Ojsteršek T; Vrečer F
Drug Dev Ind Pharm; 2018 Sep; 44(9):1543-1550. PubMed ID: 29848075
[TBL] [Abstract][Full Text] [Related]
3. Effects of manufacturing process variables on in vitro dissolution characteristics of extended-release tablets formulated with hydroxypropyl methylcellulose.
Huang Y; Khanvilkar KH; Moore AD; Hilliard-Lott M
Drug Dev Ind Pharm; 2003 Jan; 29(1):79-88. PubMed ID: 12602495
[TBL] [Abstract][Full Text] [Related]
4. Roller compaction of hydrophilic extended release tablets-combined effects of processing variables and drug/matrix former particle size.
Heiman J; Tajarobi F; Gururajan B; Juppo A; Abrahmsén-Alami S
AAPS PharmSciTech; 2015 Apr; 16(2):267-77. PubMed ID: 25273028
[TBL] [Abstract][Full Text] [Related]
5. Characterization of binary mixtures consisting of cross-linked high amylose starch and hydroxypropylmethylcellulose used in the preparation of controlled release tablets.
Rahmouni M; Lenaerts V; Massuelle D; Doelker E; Johnson M; Leroux JC
Pharm Dev Technol; 2003; 8(4):335-48. PubMed ID: 14601958
[TBL] [Abstract][Full Text] [Related]
6. Effect of Hydrophilic Polymers on the Release Rate and Pharmacokinetics of Acyclovir Tablets Obtained by Wet Granulation: In Vitro and In Vivo Assays.
Venkatesh DN; Meyyanathan SN; Kovacevic A; Zielińska A; Fonseca J; Eder P; Dobrowolska A; Souto EB
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235026
[TBL] [Abstract][Full Text] [Related]
7. Controlled-release carbamazepine matrix granules and tablets comprising lipophilic and hydrophilic components.
Barakat NS; Elbagory IM; Almurshedi AS
Drug Deliv; 2009 Jan; 16(1):57-65. PubMed ID: 19555310
[TBL] [Abstract][Full Text] [Related]
8. Correlation between the viscoelastic properties of the gel layer of swollen HPMC matrix tablets and their in vitro drug release.
Hamed R; Al Baraghthi T; Sunoqrot S
Pharm Dev Technol; 2018 Nov; 23(9):838-848. PubMed ID: 27808590
[TBL] [Abstract][Full Text] [Related]
9. Method to recover a lipophilic drug from hydroxypropyl methylcellulose matrix tablets.
Williams RO; Sykora MA; Mahaguna V
AAPS PharmSciTech; 2001 Jun; 2(2):E8. PubMed ID: 14727883
[TBL] [Abstract][Full Text] [Related]
10. Study of the critical points and the role of the pores and viscosity in carbamazepine hydrophilic matrix tablets.
Aguilar-de-Leyva A; Cifuentes C; Rajabi-Siahboomi AR; Caraballo I
Eur J Pharm Biopharm; 2012 Jan; 80(1):136-42. PubMed ID: 21946473
[TBL] [Abstract][Full Text] [Related]
11. A study of critical functionality-related characteristics of HPMC for sustained-release tablets.
Košir D; Ojsteršek T; Baumgartner S; Vrečer F
Pharm Dev Technol; 2018 Nov; 23(9):865-873. PubMed ID: 27879163
[TBL] [Abstract][Full Text] [Related]
12. Spray-dried O-carboxymethyl chitosan as potential hydrophilic matrix tablet for sustained release of drug.
Bresolin JR; Largura MC; Dalri CC; Hoffer G; Rodrigues CA; Lucinda-Silva RM
Drug Dev Ind Pharm; 2014 Apr; 40(4):503-10. PubMed ID: 23594298
[TBL] [Abstract][Full Text] [Related]
13. Flow and compaction properties of hypromellose: new directly compressible versus the established grades.
Grdešič P; Vrečer F; Ilić I
Drug Dev Ind Pharm; 2016 Nov; 42(11):1877-86. PubMed ID: 27094181
[TBL] [Abstract][Full Text] [Related]
14. Multimodal approach to characterization of hydrophilic matrices manufactured by wet and dry granulation or direct compression methods.
Kulinowski P; Woyna-Orlewicz K; Obrał J; Rappen GM; Haznar-Garbacz D; Węglarz WP; Jachowicz R; Wyszogrodzka G; Klaja J; Dorożyński PP
Int J Pharm; 2016 Feb; 499(1-2):263-270. PubMed ID: 26752087
[TBL] [Abstract][Full Text] [Related]
15. The influence of polymer content on early gel-layer formation in HPMC matrices: The use of CLSM visualisation to identify the percolation threshold.
Mason LM; Campiñez MD; Pygall SR; Burley JC; Gupta P; Storey DE; Caraballo I; Melia CD
Eur J Pharm Biopharm; 2015 Aug; 94():485-92. PubMed ID: 26143369
[TBL] [Abstract][Full Text] [Related]
16. Development of sustained-release matrix tablets of BKP-01-041 (tilorone derivative) containing Hypromellose.
Chen L; Wang F
Pharmazie; 2013 Oct; 68(10):796-9. PubMed ID: 24273882
[TBL] [Abstract][Full Text] [Related]
17. Drug release-modulating mechanism of hydrophilic hydroxypropylmethylcellulose matrix tablets: distribution of atoms and carrier and texture analysis.
Park JB; Lim J; Kang CY; Lee BJ
Curr Drug Deliv; 2013 Dec; 10(6):732-41. PubMed ID: 23855499
[TBL] [Abstract][Full Text] [Related]
18. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
Cao QR; Choi YW; Cui JH; Lee BJ
J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
[TBL] [Abstract][Full Text] [Related]
19. Characterization of 5-fluorouracil release from hydroxypropylmethylcellulose compression-coated tablets.
Wu B; Shun N; Wei X; Wu W
Pharm Dev Technol; 2007; 12(2):203-10. PubMed ID: 17510892
[TBL] [Abstract][Full Text] [Related]
20. Once-daily sustained-release matrix tablets of nicorandil: formulation and in vitro evaluation.
Reddy KR; Mutalik S; Reddy S
AAPS PharmSciTech; 2003 Dec; 4(4):E61. PubMed ID: 15198556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
